Chemo spray targets Stomach-Lining tumors in pancreatic cancer
NCT ID NCT07253662
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests a new way to deliver chemotherapy directly to the lining of the abdomen in people with pancreatic cancer that has spread there. The treatment, called PIPAC, uses a spray of chemotherapy drugs under pressure to reach tumor spots more effectively. The study aims to find out if this approach is safe and tolerable when combined with standard care. About 10 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA PANCREAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zuckerberg Cancer Center
RECRUITINGNew Hyde Park, New York, 11040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.